NextGen Omics US 2025

March 2025 | Boston, MA

Leveraging multi-omic data to unlock transformative insights into cellular biology, disease and drug discovery

Omics Hero Banner Circle Image
Overview Next Generation Sequencing & Clinical Diagnostics Single Cell & Spatial Analysis

Explore NextGen Omics US 2025: Delivering Therapeutic Innovation Through Multi-Omic Analysis

With technological advancements in NGS, single cell analysis and more, we have more data than ever to understand disease drivers – facilitating a transformative shift towards precision medicine. NextGen Omics US connects experts from across genomic, transcriptomics, proteomics and metabolomics to fast-track the adoption of multi-omic techniques within drug discovery and clinical research. Encompassing our 10th Annual Next Generation Sequencing US Congress and 10th Annual Single Cell & Spatial Analysis US Congress, you'll be able to discuss the industry’s most pressing challenges – from data analysis and reproducibility through to sample management – and build partnerships with the right people for your research goals.

10th Annual Next Generation Sequencing US Congress

Expand the applications of next-generation sequencing in your clinical & diagnostic workflows through the Next Generation Sequencing & Clinical Diagnostics US Congress, highlighting the most need-to-know innovations in diagnostics, clinical genomics & bioinformatic technologies. Industry leading speakers will showcase effective strategies for integrating NGS techniques within drug development, with further discussion on standardizing bioinformatics, optimizing NGS-based assays and utilizing multi-omic data.

  • Over 600 end users representing internationally renowned research & academic institutions, healthcare organisations and leading biopharma institutions
  • Over 50 presentations focussed on the critical issues in NGS implementation and data integration

Agenda at a Glance


  • Day One | Track 1: Advanced Sequencing Technologies
  • Day One | Track 2: Data Harmonization, Integration & Analysis
  • Day One | Track 3: Digital PCR & Liquid Biopsies
  • Day Two | Track 1: Novel Diagnostics For Infectious & Non-Infectious Disease
  • Day Two | Track 2: Applying Omics in the Clinic

10th Annual Single Cell Analysis US Congress

Recent advances in single cell analytical tools have enabled increasingly deep cellular analyses at the genomic, transcriptomic and proteomic level. Join the Single Cell Analysis Congress to learn how to integrate the most exciting new techniques within drug development, from identifying novel therapeutic targets through to understanding patient responses to specific therapies. In-depth case studies also showcase emerging spatial approaches, with discussion on how to optimize their use within R&D.

  • Over 450 end users representing internationally renowned research & academic institutions, healthcare organisations and leading biopharma institutions
  • Over 40 presentations focussed on the most innovative spatial and single cell technologies, and their applications within diagnostics, clinical research and drug discovery

Agenda at a Glance


  • Day One | Track 4: Emerging Single Cell Technologies
  • Day Two | Track 3: Bioinformatics For Single Cell Analysis
  • Day Two | Track 4: Applications Of Single Cell Technologies

What to Expect

600

leading pharma, biotech, & academic delegates

60
hours of presentations, discussions & interactive content
11
hours of networking breaks, including speed networking & refreshments
62
hours of pre-arranged 1-2-1 meetings, facilitating business growth
Interactive Presentations
Exhibition Hall
Networking Drinks
Poster Display
Event App Swapcard

Networking & knowledge-sharing is at the heart of what we do. Alongside the innovative programme, attendees can engage in a variety of event features and make the most of participation in a range of experiences

  • Engaging Thought Leadership

    Over 80 dynamic interactive discussions, roundtables, and presentations curated with insights from top industry leaders and experts
  • Global Technological Showcase

    An international exhibition showcasing cutting-edge technologies and services from leading providers in the scientific field.
  • Networking Emphasis

    Unparalleled networking opportunities, including speed networking sessions, a vibrant drinks reception, and informal gatherings to foster meaningful connections
  • Innovative Poster Displays

    Inspiring poster displays and presentations unveiling the latest breakthroughs from emerging biotech, pharma, and academic institutions

Companies Represented Include

Meet Our Expert Speakers

The event brings together a panel of prominent leaders and scientists, sharing new case studies, innovative data, and industry outlooks. Below were some of the featured speakers at NextGen Omics US 2024: 21 - 22 March 2024, Boston, MA, USA

Anna Lyubetskaya
Senior Principal Scientist,
Bristol Myers Squibb
Bin Li
Director, Computational Biology,
Takeda
Colles Price
Principal Scientist,
Takeda
Jasmine Plummer
Director,
St Jude Children's Research Hospital
Jindan Yu
Professor,
EMORY UNIVERSITY
Marina Bleck
Principal Scientist,
Boehringer Ingelheim Pharmaceuticals, Inc.

All Speakers

Ali Rahnavard
Assistant Professor,
The George Washington University
Amrut Sarangi
Computational Scientist,
Sanofi
Asaf Rotem
Senior Director,
AstraZeneca
Ashley Fletcher
Laboratory Manager / Bioinformatician,
Duke University
Changsheng Zhao
Associated professor,
Emory University
Cory White
Researcher,
Merck
Deidre Dalmas
Scientific Director,
GSK
Jason Kim
Professor and Director,
10x Genomics
Jeremy Huang
Senior Scientist - Single Cell & Systems Biology,
Sanofi
Josee Champagne
Associate Director, Clinical Development,
Northern Therapeutics
Josh Fienman
Scientist, Genomics,
Pfizer Ltd
Jun Wang
Associate Professor,
Stony Brook University New York
Kan Xiong
Senior Scientist and Group Leader,
Broad Institute
Katy Borner
Victor H. Yngve Professor of Intelligent Systems Engineering,
Indiana University Bloomington
Kyoung Jae Won Won
Professor,
Cedars-Sinai Medical Center
Liguo Wang
Associate Professor in Biomedical Informatics,
Mayo Clinic
Lindsey Erion Barner
Senior Scientist,
Broad Institute of MIT and Harvard
Mandovi Chatterjee
Director, Single Cell Core,
Harvard Medical School
Monika Mehta
Senior Genomics Scientist,
Integrated Research Facility (NIAID)
Nikolai Slavov
Professor,
Northeastern University
Ron Weiss
Professor,
MIT
Serena Dollive
Senior Scientist II,
Oxford Biomedica
Shuqiang Li
Senior Scientist,
Broad Institute
Tom Defay
Deputy Head Diagnostics Strategy & Development,
Alexion Pharmaceuticals
Towia Libermann
Associate Professor of Medicine,
Beth Israel Deaconess Medical Center
Tujin Shi
Senior Scientist,
Pacific Northwest National Laboratory
Winston Hide
Associate Professor,
Beth Israel Deaconess Medical Center / Harvard Medical School
Xingyi Shi
Expert II Data Science,
Novartis
Yasser Riazalhosseini
Associate Professor,
McGill University
Yixing Han
Staff Scientist,
National Institutes of Health
Yong Zeng
Professor,
University of Florida

Interested in Sponsoring?

Oxford Global’s range of sponsorship opportunities are highly effective in enabling market immersion and visibility, with direct access to clients and potential customers.

Learn more

Latest Resources

Roadblocks to the Sharing of Large Multi-Omics Datasets

More analysis means more data, and sharing multi-omics datasets can present challenges as well as blessings.

Research Spotlight: Multi-Omics Data Harmonization for SARS-CoV-2 Virus and Drug Target Identification

The approach to omic data analysis combines multiple types of omic datasets in the hope of understanding multiple layers of a biological system.

Post-Event Proceedings – NextGen Omics US 2023

Concise and insightful summaries of presentations delivered by prominent thought leaders at NextGen Omics US 2023.

Cutting-Edge Trends in Spatial Omics: Speaking to Jasmine Plummer, Director of the Center for Spatial Omics at St Jude Children’s Research Hospital

Jasmine Plummer is Director of the Centre for Spatial Omics at St Jude Children’s Research Hospital. We spoke to her about her work in new genomic technologies for disease treatment and development ahead of her opening keynote presentation at NextGen Omics US and Synthetic Biology US 2024.

FDA Clears Genomic Profiling Test for Solid Tumours 

Regulatory approval for comprehensive genomic profiling test signifies “significant advancement in personalised cancer care.”

Functional Genomics Reveals Major Cause of Inflammatory Bowel Disease, Discovered by UK Scientists

Genomics helped the UK-based team track down a gene that, when over expressed, was significantly responsible for causing IBD.

Plan Your Visit

Full details regarding accommodation, travel directions, health and safety, and other logistical information for the event will be added here in the coming months.

Register Your Interest

Submit your details and a member of our team will be in touch